InsiderDB

Lobbying disclosures · Lobbying report

TMO: second_quarter 2026 lobbying report

General discussions regarding impact of U.S. federal government workforce changes on industry. General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061:

Follow TMO
Became public
Jul 13, 2026, 2:43 PM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 6:48 PM EST

Why this is connected

Exact legal-name match: THERMO FISHER SCIENTIFIC INC. (https://www.sec.gov/Archives/edgar/data/97745/).

Reported lobbying amounts

Expenses: $280,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/767d51f7-7f17-49a7-9be4-d19c4433eb1f/","filing_uuid":"767d51f7-7f17-49a7-9be4-d19c4433eb1f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/767d51f7-7f17-49a7-9be4-d19c4433eb1f/print/","filing_document_content_type":"text/html","income":null,"expenses":"280000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Timothy Fenton","dt_posted":"2026-07-13T14:43:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"168 Third Avenue","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Waltham","registrant_state":"MA","registrant_zip":"02454","registrant":{"id":323251,"url":"https://lda.gov/api/v1/registrants/323251/","house_registrant_id":39694,"name":"THERMO FISHER SCIENTIFIC INC.","description":"Scientific equipment, technologies and supplies","address_1":"168 Third Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Waltham","state":"MA","state_display":"Massachusetts","zip":"02454","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIA CHEN","contact_telephone":"+1 781-577-8405","dt_updated":"2026-07-10T16:09:57.974170-04:00"},"client":{"id":187246,"url":"https://lda.gov/api/v1/clients/187246/","client_id":12,"name":"THERMO FISHER SCIENTIFIC INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1899-12-30"},"lobbying_activities":[{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"General discussions regarding impact of U.S. federal government workforce changes on industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":65,"name":"General Services Administration (GSA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Regulation for Federal Financial Assistance (OMB-2026-0034).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"Preparedness products and services. General discussions around government contracting opportunities.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"POWER Act; all provisions of the bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

-0.07% TMO

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in TMO

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.